258 related articles for article (PubMed ID: 28663255)
1. Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels.
Rydén M; Arner P
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1782-1787. PubMed ID: 28663255
[TBL] [Abstract][Full Text] [Related]
2. In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters.
Tuvdendorj D; Munoz AO; Ruiz-Barros V; Schwarz JM; Montalto G; Chandalia M; Sowers LC; Rizzo M; Murphy EJ; Abate N
Atherosclerosis; 2016 Aug; 251():147-152. PubMed ID: 27323227
[TBL] [Abstract][Full Text] [Related]
3. Circulating IL-6 concentrations and abdominal adipocyte isoproterenol-stimulated lipolysis in women.
Morisset AS; Huot C; Légaré D; Tchernof A
Obesity (Silver Spring); 2008 Jul; 16(7):1487-92. PubMed ID: 18451782
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia.
Frayn K; Bernard S; Spalding K; Arner P
J Am Heart Assoc; 2012 Dec; 1(6):e003467. PubMed ID: 23316323
[TBL] [Abstract][Full Text] [Related]
5. Adipose Insulin Resistance Associates With Dyslipidemia Independent of Liver Resistance and Involves Early Hormone Signaling.
Kerr AG; Andersson DP; Dahlman I; Rydén M; Arner P
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):1054-1065. PubMed ID: 37051928
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism.
Rydén M; Arner P
J Intern Med; 2017 Sep; 282(3):220-228. PubMed ID: 28635127
[TBL] [Abstract][Full Text] [Related]
7. In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy.
Huda SS; Forrest R; Paterson N; Jordan F; Sattar N; Freeman DJ
Hypertension; 2014 May; 63(5):1094-101. PubMed ID: 24591340
[TBL] [Abstract][Full Text] [Related]
8. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte beta-adrenoceptor sensitivity influences plasma lipid levels.
Arner P; Wahrenberg H; Lönnqvist F; Angelin B
Arterioscler Thromb; 1993 Jul; 13(7):967-72. PubMed ID: 8391311
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.
Langin D
Pharmacol Res; 2006 Jun; 53(6):482-91. PubMed ID: 16644234
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study.
Rydén M; Andersson DP; Bergström IB; Arner P
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1870-6. PubMed ID: 24937536
[TBL] [Abstract][Full Text] [Related]
12. Low early B-cell factor 1 (EBF1) activity in human subcutaneous adipose tissue is linked to a pernicious metabolic profile.
Petrus P; Mejhert N; Gao H; Bäckdahl J; Arner E; Arner P; Rydén M
Diabetes Metab; 2015 Dec; 41(6):509-12. PubMed ID: 25791133
[TBL] [Abstract][Full Text] [Related]
13. Abdominal adipose tissue and serum HDL-cholesterol: association independent from obesity and serum triglyceride concentration.
Després JP; Tremblay A; Pérusse L; Leblanc C; Bouchard C
Int J Obes; 1988; 12(1):1-13. PubMed ID: 2966132
[TBL] [Abstract][Full Text] [Related]
14. Regional differences in adipose tissue metabolism in obese men.
Boivin A; Brochu G; Marceau S; Marceau P; Hould FS; Tchernof A
Metabolism; 2007 Apr; 56(4):533-40. PubMed ID: 17379013
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women.
Berman DM; Nicklas BJ; Ryan AS; Rogus EM; Dennis KE; Goldberg AP
Obes Res; 2004 Jan; 12(1):32-9. PubMed ID: 14742840
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study.
Sekhar RV; Patel SG; D'Amico S; Shi J; Balasubramanyam A; Rehman K; Jahoor F; Visnegarwala F
Metabolism; 2011 Jun; 60(6):754-60. PubMed ID: 20832829
[TBL] [Abstract][Full Text] [Related]
17. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
[TBL] [Abstract][Full Text] [Related]
18. The relationships of abdominal obesity, hyperinsulinemia and saturated fat intake to serum lipid levels: the Normative Aging Study.
Ward KD; Sparrow D; Vokonas PS; Willett WC; Landsberg L; Weiss ST
Int J Obes Relat Metab Disord; 1994 Mar; 18(3):137-44. PubMed ID: 8186810
[TBL] [Abstract][Full Text] [Related]
19. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
[TBL] [Abstract][Full Text] [Related]
20. Human fat cell lipolysis: biochemistry, regulation and clinical role.
Arner P
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):471-82. PubMed ID: 16311212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
